Empiric treatment with once-daily cefonicid and gentamicin for febrile non-neutropenic pediatric cancer patients with indwelling central venous catheters

Journal of Pediatric Hematology/Oncology

Volumn 30, Issue 7, 2008, Pages 527-532

  Averbuch, Diana ^a   Makhoul, Rola ^b   Rotshild, Victoria ^b   Weintraub, Michael ^a   Engelhard, Dan ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b Department of Clinical Pharmacy ^*  (Israel)

Author keywords

Cefonicid; Central venous catheter; Non neutropenic fever; Pediatric cancer

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFEPIME; CEFONICID; CEFTRIAXONE; CEFUROXIME; CLINDAMYCIN; GENTAMICIN; OXACILLIN; PENICILLIN G; PIPERACILLIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ABSENCE OF SIDE EFFECTS; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BETA THALASSEMIA; CELLULITIS; CENTRAL VENOUS CATHETER; CHILD; CHILDHOOD CANCER; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEVER; HEMATOLOGIC MALIGNANCY; HISTIOCYTOSIS X; HUMAN; INCIDENCE; INDWELLING CATHETER; INFANT; INFECTION SENSITIVITY; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; METACHROMATIC LEUKODYSTROPHY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYELODYSPLASTIC SYNDROME; NEUROBLASTOMA; NEUTROPENIA; NEUTROPHIL COUNT; OUTPATIENT CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SOLID TUMOR; STREPTOCOCCUS MILLERI; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; URINARY TRACT INFECTION; WOLMAN DISEASE; BLOOD DISEASE; CENTRAL VENOUS CATHETERIZATION; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG SCREENING; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MALE; MICROBIOLOGY; NEOPLASM; OUTPATIENT; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; STATISTICS;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CEFONICID; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; DRUG THERAPY, COMBINATION; FEMALE; FEVER; GENTAMICINS; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; INFANT; MALE; NEOPLASMS; OUTPATIENTS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 54449083570     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181754184     Document Type: Article

References (23)

1. Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002;34:730-751.
2. Gorelick MH, Owen WC, Seibel NL, et al. Lack of association between neutropenia and the incidence of bacteremia associated with indwelling central venous catheters in febrile pediatric cancer patients. Pediatr Infect Dis J. 1991;10:506-510.
3. Kumar L, Kochupillai V, Bhujwala RA. Infections in acute myeloid leukemia. Study of 184 febrile episodes. J Assoc Physicians India.1992;40:18-20.
4. Rahiala J, Perkkio M, Riikonen P. Infections occurring during the courses of anticancer chemotherapy in children with ALL: a retrospective analysis of 59 patients. Pediatr Hematol Oncol. 1998; 15:165-174.
5. Adler A, Yaniv I, Steinberg R, et al. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients. J Hosp Infect. 2006;62:358-365.
6. Aledo A, Heller G, Ren L, et al. Septicemia and septic shock in pediatric patients: 140 consecutive cases on a pediatric hematologyoncology service. J Pediatr Hematol Oncol. 1998;20:215-221.
7. Salzer W, Steinberg SM, Liewehr DJ, et al. Evaluation and treatment of fever in the non-neutropenic child with cancer. J Pediatr Hematol Oncol. 2003;25:606-612.
8. Furlanut M, D'Elia R, Riva E, et al. Pharmacokinetics of cefonicid in children. Eur J Clin Pharmacol. 1989;36:79-82.
9. Viscoli C, Castagnola E, Giacchino M, et al. Bloodstream infections in children with cancer: a multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology. Supportive therapy group-infectious diseases section. Eur J Cancer.1999;35:770-774.
10. Viscoli C, Garaventa A, Boni L, et al. Role of Broviac catheters in infections in children with cancer. Pediatr Infect Dis J. 1988;7: 556-560.
11. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2002;51: 1-29.
12. Abbas AA, Fryer CJ, Paltiel C, et al. Factors influencing central line infections in children with acute lymphoblastic leukemia: results of a single institutional study. Pediatr Blood Cancer. 2004;42: 325-331.
13. Keung YK, Watkins K, Chen SC, et al. Comparative study of infectious complications of different types of chronic central venous access devices. Cancer. 1994;73:2832-2837.
14. Simon A, Fleischhack G, Hasan C, et al. Surveillance for nosocomial and central line-related infections among pediatric hematology-oncology patients. Infect Control Hosp Epidemiol. 2000;21: 592-596.
15. McLean TW, Fisher CJ, Snively BM, et al. Central venous lines in children with lesser risk acute lymphoblastic leukemia: optimal type and timing of placement. J Clin Oncol. 2005;23:3024-3029.
16. Groeger JS, Lucas AB, Thaler HT, et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med. 1993;119:1168-1174.
17. Ingram J, Weitzman S, Greenberg ML, et al. Complications of indwelling venous access lines in the pediatric hematology patient: a prospective comparison of external venous catheters and subcutaneous ports. Am J Pediatr Hematol Oncol. 1991;13:130-136.
18. La Quaglia MP, Lucas A, Thaler HT, et al. A prospective analysis of vascular access device-related infections in children. J Pediatr Surg.1992;27:840-842.
19. Mirro J Jr, Rao BN, Kumar M, et al. A comparison of placement techniques and complications of externalized catheters and implantable port use in children with cancer. J Pediatr Surg. 1990;25:120-124.
20. Castagnola E, Conte M, Parodi S, et al. Incidence of bacteremias and invasive mycoses in children with high risk neuroblastoma. Pediatr Blood Cancer. 2007;49:672-677.
21. Verbist L, Verhaegen J. In vitro activity of cefonicid compared to other antibiotics against clinical bacterial isolates. Acta Clin Belg.1990;45:113-119.
22. Barry AL, Jones RN, Packer RR. Antistaphylococcal activity of ceforanide and cefonicid in the presence of human serum. Antimicrob Agents Chemother. 1986;29:147-149.
23. Chambers HF, Mills J, Drake TA, et al. Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus. Rev Infect Dis. 1984;6(supp 4):S870-S874.